Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Shares Outstanding (Weighted Average) (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Shares Outstanding (Weighted Average) data on record, last reported at $39.8 million in Q3 2021.

  • For Q3 2021, Shares Outstanding (Weighted Average) rose 304.54% year-over-year to $39.8 million; the TTM value through Sep 2021 reached $39.8 million, up 304.54%, while the annual FY2020 figure was $11.1 million, 45.42% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $39.8 million in Q3 2021 per COGT's latest filing, up from $36.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $39.8 million in Q3 2021 and bottomed at $7.5 million in Q1 2020.
  • Average Shares Outstanding (Weighted Average) over 4 years is $20.5 million, with a median of $19.7 million recorded in 2018.
  • Peak YoY movement for Shares Outstanding (Weighted Average): plummeted 74.96% in 2020, then surged 371.49% in 2021.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $24.9 million in 2018, then plummeted by 69.39% to $7.6 million in 2019, then skyrocketed by 45.42% to $11.1 million in 2020, then soared by 259.61% to $39.8 million in 2021.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $39.8 million in Q3 2021, $36.7 million in Q2 2021, and $34.9 million in Q1 2021.